Skip to main content
SpringerLink
Log in

Canadian reimbursement: publicly-insured get short shrift

  • Comment
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Skinner BJ.Waiting for reimbursement of new medicines in Canada: it's time for a rethink. PharmacoEconomics 26: 629-632, No. 8, Jan 2008

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Canadian reimbursement: publicly-insured get short shrift. Pharmacoecon. Outcomes News 559, 5 (2008). https://doi.org/10.2165/00151234-200805590-00013

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200805590-00013

Keywords

Search

Navigation